345 related articles for article (PubMed ID: 16098652)
1. Medical management of incidents with chemical warfare agents.
Zilker T
Toxicology; 2005 Oct; 214(3):221-31. PubMed ID: 16098652
[TBL] [Abstract][Full Text] [Related]
2. Combined chemical and conventional injuries--pathophysiological, diagnostic and therapeutic aspects.
Berkenstadt H; Marganitt B; Atsmon J
Isr J Med Sci; 1991; 27(11-12):623-6. PubMed ID: 1757234
[TBL] [Abstract][Full Text] [Related]
3. Toxicological aspects of preparedness and aftercare for chemical-incidents.
Schwenk M; Kluge S; Jaroni H
Toxicology; 2005 Oct; 214(3):232-48. PubMed ID: 16118031
[TBL] [Abstract][Full Text] [Related]
4. Chemical warfare agents.
Kuca K; Pohanka M
EXS; 2010; 100():543-58. PubMed ID: 20358695
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning.
Balali-Mood M; Hefazi M
Fundam Clin Pharmacol; 2005 Jun; 19(3):297-315. PubMed ID: 15910653
[TBL] [Abstract][Full Text] [Related]
6. Nerve agents: pathophysiology and treatment of poisoning.
Newmark J
Semin Neurol; 2004 Jun; 24(2):185-96. PubMed ID: 15257516
[TBL] [Abstract][Full Text] [Related]
7. Role of the emergency physician in treatment of the poisoned patient.
Guzzardi LJ
Emerg Med Clin North Am; 1984 Feb; 2(1):3-13. PubMed ID: 6519022
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Iranian soldiers attacked by chemical and microbiological war gases.
Heyndrickx A; Heyndrickx B
Arch Belg; 1984; Suppl():57-9. PubMed ID: 6535497
[No Abstract] [Full Text] [Related]
9. Mass casualty chemical exposure and implications for respiratory failure.
Muskat PC
Respir Care; 2008 Jan; 53(1):58-63; discussion 63-6. PubMed ID: 18173860
[TBL] [Abstract][Full Text] [Related]
10. [Nerve paralytic agents--the greatest threat for mass poisoning during chemical warfare or terrorist attacks].
Kassa J
Cas Lek Cesk; 2001 Dec; 140(24):745-51. PubMed ID: 14655276
[TBL] [Abstract][Full Text] [Related]
11. Antidotes and treatments for chemical warfare/terrorism agents: an evidence-based review.
Rodgers GC; Condurache CT
Clin Pharmacol Ther; 2010 Sep; 88(3):318-27. PubMed ID: 20686476
[TBL] [Abstract][Full Text] [Related]
12. Development of antidotes: problems and strategies.
Szinicz L; Worek F; Thiermann H; Kehe K; Eckert S; Eyer P
Toxicology; 2007 Apr; 233(1-3):23-30. PubMed ID: 16949190
[TBL] [Abstract][Full Text] [Related]
13. Chemical warfare issues.
Hollinger M
Crit Care Nurse; 2004 Feb; 24(1):14; author reply 14. PubMed ID: 15007887
[No Abstract] [Full Text] [Related]
14. [Principles of the prevention and treatment of lesions from toxic agents].
Polumiskov IuM; Cherniak SI
Voen Med Zh; 1975 Aug; (8):15-8. PubMed ID: 1179660
[No Abstract] [Full Text] [Related]
15. Old antidotes, new antidotes, and a 'universal antidote': what should we be using for pediatric poisoning?
Liebelt EL
Curr Opin Pediatr; 2007 Apr; 19(2):199-200. PubMed ID: 17496765
[No Abstract] [Full Text] [Related]
16. Aerosolized atropine as an antidote to nerve gas.
Orma PS; Middleton RK
Ann Pharmacother; 1992; 26(7-8):937-8. PubMed ID: 1504407
[No Abstract] [Full Text] [Related]
17. [In-hospital management of victims of chemical weapons of mass destruction].
Barelli A; Gargano F; Proietti R
Ann Ist Super Sanita; 2005; 41(1):93-101. PubMed ID: 16037657
[TBL] [Abstract][Full Text] [Related]
18. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning.
DeLorenzo RA
JEMS; 2001 Jun; 26(6):48-57. PubMed ID: 11409202
[No Abstract] [Full Text] [Related]
19. Therapeutic options to treat sulfur mustard poisoning--the road ahead.
Smith WJ
Toxicology; 2009 Sep; 263(1):70-3. PubMed ID: 18852011
[TBL] [Abstract][Full Text] [Related]
20. [Nerve gas--guidelines for care of victims of terrorism].
Aas P; Jacobsen D
Tidsskr Nor Laegeforen; 2005 Mar; 125(6):731-5. PubMed ID: 15776066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
